| ||||||||||||||||||
 Trade In this Item for up to £0.25
Get an extra £5 when you trade in books worth £10 or more until June 30, 2012. Trade in From Alchemy to IPO: The Business of Biotechnology for an Amazon.co.uk gift card of up to £0.25, which you can then spend on millions of items across the site. Trade-in values may vary (terms apply). Find more products eligible for trade-in.
|
Frequently Bought Together
Product details
|
More About the Author
Product Description
Review
"A fascinating glimpse inside the life-and-death business of biotechnology. A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth." -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers "From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can." -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen"
Product Description
A fascinating glimpse inside the life-and-death business of biotechnology. "A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."-Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers"From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can."-George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, AmgenWritten by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it.
Inside This Book
(Learn More)
First Sentence
"Fourteen years ago, Betsy Patterson was a 34-year-old single mom with three kids ages 5 to 10." Read the first page
Front Cover | Copyright | Table of Contents | Excerpt | Index | Back Cover
"Fourteen years ago, Betsy Patterson was a 34-year-old single mom with three kids ages 5 to 10." Read the first page
Explore More
Concordance
Browse Sample PagesConcordance
Front Cover | Copyright | Table of Contents | Excerpt | Index | Back Cover
Tags Customers Associate with This Product(What's this?)Click on a tag to find related items, discussions, and people.
|
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
What Other Items Do Customers Buy After Viewing This Item?
Customer Reviews
Most Helpful Customer Reviews
6 of 6 people found the following review helpful
Format:Hardcover
If only every new technology had such an introduction. CRR is an insider, believes in her discipline yet writes with clarity and keeps the right distance from the subject. For somebody who doesn't know but wants to get a summary of the drivers, the key technologies, the problems and the promises of biotech with a good level of detail, it's an excellent way to start. You won't get great stock tips here (don't be fooled by the company listings etc) but you'll be get a fair bit of an idea about what differentiates a successful company from the pack. Few authors can promise and deliver more than that. Fair amount about financing of the business etc - although I personally found a bit more historic detail than I would ask for. Audience: investors (professional or amateur), traders, bankers and startup enterpreneurs. Good job.
Most Helpful Customer Reviews on Amazon.com (beta)
Amazon.com:
24 reviews
26 of 28 people found the following review helpful
From Alchemy to IPO --the REAL biotech story revealed!
18 May 2000
Format:Hardcover
This is flat out the best book I've read on the biotechnology industry. I found it a riveting journey through both the science and the business of biotechnology, as well as a fascinating introduction to some of the outsize personalities who have invented the industry. The author, Cynthia Robbins-Roth, has a knack for translating complicated science and business issues into language that is both entertaining and, most importantly, understandable (thank you!). This book would make a great movie!
18 of 19 people found the following review helpful
Great Overview/Explanation of the Biotech Industry!
3 Dec 2000
Format:Hardcover
I have stayed away from investing in drugs and biotechs for over 5 years. That is not my area of expertise. This book is great in being a teacher of biotech history and technology. It ties in biotech implications very well with drug development, agriculture, and other roles it will have in society. If you want to learn biotech for the fun of it or because you want to start investing in biotech/genomics, this is a must read. I have to warn you though, after reading this book, I have come to the conclusion that I will be buying a biotech fund instead of buying biotech companies. The book makes things seem to complex and unpredicatbale for picking individual companies for the long term investment prospects. They are just too many and their success is largely reliant on chance and luck. Even if you are a daytrader or swingtrader, by improving your knowledge of the biotech industry, you will improve your chances of making money when you know what the press releases are talking about.
Let me finish with why I did not rate this book a 5. The wording that the author chooses is sometimes unclear and downright annoying. There were at least 5 spots where I had to stop and ask myself. Am I just stupid for not understanding what the author is trying to say, or is this written in caveman English. I came to the conclusion that the unclear sentences were the fault of the author. I have read many business/investing books where the author writes concise and flowing text. This book was annoying to read at times because of Robbins-Roth's wordings.
11 of 11 people found the following review helpful
making sense out of chaos
25 May 2000
Format:Hardcover
dr. robbins-roth's book is the best example i've seen of a text which makes sense of the short yet tangled history of the biotech business. from it's beginning, the biotech business has attracted the dreamers, the -don't-know-how-we'll-get- there-but-we-must-get-there types, and the scientific whiz-kids. this book not only charts the progress of the companies and the products, it also delves into the science and personalities behind the scene. this book is written at a level accessible to the layman, but is complex enough that professionals in the biological sciences will not find it too pedestrian. this is one of the most interesting, hardest-to-put-down science books i've read in many years.
Were these reviews helpful?
Let us know
Listmania!
Look for similar items by category
- Books > Business, Finance & Law > Biographies & Histories > Business & Economic History
- Books > Business, Finance & Law > Careers > Entrepreneurship
- Books > Business, Finance & Law > Economics
- Books > Business, Finance & Law > Management
- Books > Business, Finance & Law > Professional Finance
- Books > Business, Finance & Law > Small Business & Entrepreneurship > Entrepreneurship
- Books > History > Social & Economic History > Inventions
- Books > Science & Nature > Engineering & Technology > Bioengineering > Biotechnology
- Books > Science & Nature > Engineering & Technology > Chemical > Industrial Chemistry
Look for similar items by subject
Feedback
- Would you like to update product info or give feedback on images?
- I am the Author, and I want to comment on my book.
- I am the Publisher, and I want to comment on this book.
|
